Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia-Reference-Cited by-同舟云学术

Neurobehavioral and neurobiochemical effect of atomoxetine and N-acetylcysteine in streptozotocin diabetes induced endothelial dysfunction and related dementia

Published:2022-05 Issue: Volume:249 Page:113767
ISSN:0031-9384
Container-title:Physiology & Behavior
language:en
Short-container-title:Physiology & Behavior

Author:

Aggarwal Himanshu,Gupta Surbhi,Sharma Poonam,Sharma BM,Sharma Bhupesh

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Experimental and Cognitive Psychology

Reference44 articles.

1. Vascular dementia;O'Brien;Lancet N. Am. Ed.,2015

2. Cholinergic deficiency involved in vascular dementia–Possible mechanism and strategy of treatment;Wang;Acta Pharmacol. Sin.,2009

3. Alzheimer's disease is type 3 diabetes–Evidence reviewed;De la Monte;J. Diabetes Sci. Technol.,2008

4. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas;Szkudelski;Physiol. Res.,2001

5. Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer's disease and vascular dementia;Murtishaw;Neuropharmacology,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of N-acetylcysteine supplementation on endothelial function: a systematic review;Clinical Nutrition Open Science;2023-12

2. Flutamide Alters Markers of Inflammation and Oxidative stress in Experimental Model of Autism;Research Journal of Pharmacy and Technology;2023-11-30

3. Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease;Molecules;2023-09-12

4. Piperidine Nucleus as a Promising Scaffold for Alzheimer’s Disease: Current Landscape and Future Perspective;Current Topics in Medicinal Chemistry;2023-05

5. Calcium Channels as a Potential Therapeutic Target for Alzheimer’s Disease;Deciphering Drug Targets for Alzheimer’s Disease;2023